TECTONIC THERAPEUTIC, INC. Adjustments to Additional Paid in Capital, Other
TECTONIC THERAPEUTIC, INC. (TECX) reported Adjustments to Additional Paid in Capital, Other of $9.30 million for the 3-month period ending 2025-03-31, per its 10-Q filed 2025-05-08.
Financial Statements › Shareholders' Equity › Adjustments to Additional Paid in Capital
us-gaap:AdjustmentsToAdditionalPaidInCapitalOther · last filed 2026-02-26
- TECTONIC THERAPEUTIC, INC. adjustments to additional paid in capital, other for the quarter ending 2025-03-31 was $9.30M.
- TECTONIC THERAPEUTIC, INC. adjustments to additional paid in capital, other for the quarter ending 2024-12-31 was -$600.00K.
- TECTONIC THERAPEUTIC, INC. adjustments to additional paid in capital, other for fiscal 2024 was $9.30M.
| Period end | Adjustments to Additional Paid in Capital, Other 3 month | Adjustments to Additional Paid in Capital, Other 6 month | Adjustments to Additional Paid in Capital, Other 9 month | Adjustments to Additional Paid in Capital, Other 12 month |
|---|---|---|---|---|
| 2025-03-31 | $9.30M 10-Q · filed 2025-05-08 | $8.70M derived: sum of 2 quarters · filed 2026-02-26 | ||
| 2024-12-31 | -$600.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $9.30M 10-K · filed 2026-02-26 | ||
| 2024-09-30 | $9.90M 10-Q · filed 2024-11-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| REGENXBIO Inc. (RGNX) | United States | $0.477B | -3.30 |
| Entera Bio Ltd. (ENTX) | $0.485B | ||
| Eikon Therapeutics, Inc. (EIKN) | United States | $0.446B | |
| Kyverna Therapeutics, Inc. (KYTX) | United States | $0.434B | -3.60 |
| Autolus Therapeutics plc (AUTL) | $0.506B | -1.52 | |
| Editas Medicine, Inc. (EDIT) | United States | $0.424B | -4.29 |
| Scribe Therapeutics, Inc. (SCTX) | United States | $0.410B | |
| Zura Bio Ltd (ZURA) | $0.398B | -6.56 | |
| Surrozen, Inc./DE (SRZN) | United States | $0.395B | |
| AGENUS INC (AGEN) | United States | $0.383B | 1.41 |